Psyence Biomedical (PBM) Assets (2022 - 2026)

Psyence Biomedical has reported Assets for 5 years, with the latest figure at $17.6 million in Q1 2026.

• On a quarterly basis, Assets rose 140.11% year-over-year to $17.6 million in Q1 2026; TTM through Mar 2026 was $17.6 million, a 140.11% increase from a year earlier, with the FY2026 full-year figure at $17.6 million, up 140.11% from the prior year.
• Assets was $17.6 million for Q1 2026 at Psyence Biomedical, up from $12.8 million in the prior quarter.
• The five-year high for Assets was $258.9 million in Q4 2022, with the low at $1.6 million in Q1 2023.
• Average Assets over 5 years is $39.3 million, with a median of $10.0 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Assets plunged 82.23% in 2024, then soared 468.46% in 2025.
• Over 5 years, Assets stood at $258.9 million in 2022, then slumped by 95.1% to $12.7 million in 2023, then slumped by 82.23% to $2.3 million in 2024, then jumped by 468.46% to $12.8 million in 2025, then jumped by 37.14% to $17.6 million in 2026.
• The last three Assets figures came in at $17.6 million (Q1 2026), $12.8 million (Q3 2025), and $7.3 million (Q1 2025), per Business Quant data.